Survivin - biology and potential as a therapeutic target in oncology

Chun-Hei Cheung, Chien Chang Huang, Fang Ying Tsai, Jane Ying Chieh Lee, Siao Muk Cheng, Yung Chieh Chang, Yi Chun Huang, Shang Hung Chen, Jang-Yang Chang

Research output: Contribution to journalReview article

82 Citations (Scopus)

Abstract

Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.

Original languageEnglish
Pages (from-to)1453-1462
Number of pages10
JournalOncoTargets and Therapy
Volume6
DOIs
Publication statusPublished - 2013 Oct 28

Fingerprint

Inhibitor of Apoptosis Proteins
Post Translational Protein Processing
Acetylation
Drug Resistance
PubMed
Neoplasms
Phosphorylation
Databases
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

Cheung, Chun-Hei ; Huang, Chien Chang ; Tsai, Fang Ying ; Lee, Jane Ying Chieh ; Cheng, Siao Muk ; Chang, Yung Chieh ; Huang, Yi Chun ; Chen, Shang Hung ; Chang, Jang-Yang. / Survivin - biology and potential as a therapeutic target in oncology. In: OncoTargets and Therapy. 2013 ; Vol. 6. pp. 1453-1462.
@article{208b264e503448d28f4d45d4b1159c06,
title = "Survivin - biology and potential as a therapeutic target in oncology",
abstract = "Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus{\circledR} (Elsevier, New York, NY, USA), and SciFinder{\circledR} (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.",
author = "Chun-Hei Cheung and Huang, {Chien Chang} and Tsai, {Fang Ying} and Lee, {Jane Ying Chieh} and Cheng, {Siao Muk} and Chang, {Yung Chieh} and Huang, {Yi Chun} and Chen, {Shang Hung} and Jang-Yang Chang",
year = "2013",
month = "10",
day = "28",
doi = "10.2147/OTT.S33374",
language = "English",
volume = "6",
pages = "1453--1462",
journal = "OncoTargets and Therapy",
issn = "1178-6930",
publisher = "Dove Medical Press Ltd.",

}

Cheung, C-H, Huang, CC, Tsai, FY, Lee, JYC, Cheng, SM, Chang, YC, Huang, YC, Chen, SH & Chang, J-Y 2013, 'Survivin - biology and potential as a therapeutic target in oncology', OncoTargets and Therapy, vol. 6, pp. 1453-1462. https://doi.org/10.2147/OTT.S33374

Survivin - biology and potential as a therapeutic target in oncology. / Cheung, Chun-Hei; Huang, Chien Chang; Tsai, Fang Ying; Lee, Jane Ying Chieh; Cheng, Siao Muk; Chang, Yung Chieh; Huang, Yi Chun; Chen, Shang Hung; Chang, Jang-Yang.

In: OncoTargets and Therapy, Vol. 6, 28.10.2013, p. 1453-1462.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Survivin - biology and potential as a therapeutic target in oncology

AU - Cheung, Chun-Hei

AU - Huang, Chien Chang

AU - Tsai, Fang Ying

AU - Lee, Jane Ying Chieh

AU - Cheng, Siao Muk

AU - Chang, Yung Chieh

AU - Huang, Yi Chun

AU - Chen, Shang Hung

AU - Chang, Jang-Yang

PY - 2013/10/28

Y1 - 2013/10/28

N2 - Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.

AB - Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.

UR - http://www.scopus.com/inward/record.url?scp=84886067499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886067499&partnerID=8YFLogxK

U2 - 10.2147/OTT.S33374

DO - 10.2147/OTT.S33374

M3 - Review article

AN - SCOPUS:84886067499

VL - 6

SP - 1453

EP - 1462

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

SN - 1178-6930

ER -